ANOKA MARTIS

Allopathic & Osteopathic Physicians|Internal Medicine TERRE HAUTE, IN NPI 1336634591

General Payments — all program years on this page

$2,333.31

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 121
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $936.59 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $936.5941

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $129.768
2022 $465.1429
2023 $801.8243
2024 $936.5941

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078020444 Janssen Pharmaceuticals, Inc $18.34 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086233971 Bayer Healthcare Pharmaceuticals Inc. $17.43 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086263476 Bayer Healthcare Pharmaceuticals Inc. $16.62 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021072 Novartis Pharmaceuticals Corporation $20.88 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021078 Novartis Pharmaceuticals Corporation $23.45 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021088 Novartis Pharmaceuticals Corporation $25.01 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021090 Novartis Pharmaceuticals Corporation $20.82 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087021098 Novartis Pharmaceuticals Corporation $20.74 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097303469 Novo Nordisk Inc $17.48 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097399748 Novo Nordisk Inc $13.66 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097500328 Novo Nordisk Inc $12.38 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097526498 Novo Nordisk Inc $20.25 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097564214 Novo Nordisk Inc $17.14 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097702608 Novo Nordisk Inc $124.74 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097737986 Novo Nordisk Inc $20.72 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097818900 Novo Nordisk Inc $13.03 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104544310 AstraZeneca Pharmaceuticals LP $17.68 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104977469 ABBVIE INC. $16.09 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104977471 ABBVIE INC. $16.98 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104977473 ABBVIE INC. $16.70 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105456748 AstraZeneca Pharmaceuticals LP $13.77 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105525365 AstraZeneca Pharmaceuticals LP $16.43 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105703690 AstraZeneca Pharmaceuticals LP $25.30 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105732431 AstraZeneca Pharmaceuticals LP $15.44 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110730515 Eisai Inc. $16.08 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114775443 Exact Sciences Corporation $22.30 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116169116 GlaxoSmithKline, LLC. $13.16 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118936976 Otsuka America Pharmaceutical, Inc. $21.24 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130945329 PFIZER INC. $15.55 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131047999 PFIZER INC. $19.45 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131354285 PFIZER INC. $16.94 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135999831 Lilly USA, LLC $20.45 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136042884 Lilly USA, LLC $18.82 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136042886 Lilly USA, LLC $17.07 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136045439 Lilly USA, LLC $10.32 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136045441 Lilly USA, LLC $102.02 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136045443 Lilly USA, LLC $14.82 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136046183 Lilly USA, LLC $17.89 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136049795 Lilly USA, LLC $18.25 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151093871 Phathom Pharmaceuticals, Inc. $26.94 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281661 Dexcom, Inc. $24.21 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.